Journals / Retina-Vitreus / 2006 / Cilt: 14 - Sayı: 4

The use of silicon oil in vitreoretinal surgery

Vitreoretinal cerrahide silikon yağı kullanımı

Pages
321–328
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The indications and complications with silicone oil in vitreoretinal surgery are discussed in this article.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The beginning of using silicone oil in 1962s dramatically improved the quality of posterior segment surgery.
📊
Key Findings & Data:The purpose of silicone oil vitreous substitution is to provide long-term tamponade of the retina.
💡
Conclusion & Impact:The indications and complications with silicone oil in vitreoretinal surgery are discussed in this article.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The beginning of using silicone oil in 1962s dramatically improved the quality of posterior segment surgery. The purpose of silicone oil vitreous substitution is to provide long-term tamponade of the retina. The most commonly used silicone oil in ophthalmology is polydimethylsiloxane. Silicon oil is used especially in retinal detachments with giant breaks with rolled-over retina, retinal detachment with Proliferative Vitreoretinopathy (PVR), and retinal detachment with advanced atrophy and multiple breaks. Silicone oil can result in a number of complications. Cataract is probably inevitable in eyes permanently filled with silicone oil. Glaucoma can result from pupillary block. Keratopathy occurs if the anterior chamber is filled with silicone. Because of its potential complications, silicone oil is generally removed from eyes in which it is considered safe to do so once the process of PVR has become quiescent. Silicone removal is associated with a considerable risk of retinal redetachment. The indications and complications with silicone oil in vitreoretinal surgery are discussed in this article.

Özet

1962 yılında silikon yağlarının kullanımının başlaması ile arka segment cerrahisinin kalitesinde önemli derecede düzelme sağlandı. Silikon yağının vitreusla yer değiştirilmesindeki esas amaç uzun süre retinal tamponadın sağlanmasıdır. Oftalmolojide en sık kullanılan silikon yağı polidimetilsiloksandır. Silikon yağı özellikle dev yırtıklı, proliferatif vitreoretinopati (PVR) ile birlikte olan ve çok sayıda yırtık ve retina atrofisi ile seyreden retina dekolmanlarında kullanılmaktadır. Silikon yağı kullanımının getirdiği bir takım yan etkiler mevcuttur. Silikon ile dolu gözlerde katarakt büyük olasılıkla kaçınılmazdır. Pupiller blok sonucu glokom oluşabilir. Silikonun ön kamaraya geçtiği durumlarda keratopati gelişebilir. Silikon yağının potansiyel yan etkilerinden dolayı PVR nin meydana gelmediği ve işlemin güvenilir olduğu bir zamanda gözden alınması gerekmektedir. Silikon yağı alınımı sonrası nüks retina dekolmanı gelişebilmektedir. Biz bu yazımızda vitreoretinal cerrahide silikon yağı kullanım endikasyonları ve meydana gelebilecek yan etkileri irdeledik.

🔖

Cite This Article

ÇITIRIK, M., BATMAN, C., ZİLELİOĞLU, O. (2006). The use of silicon oil in vitreoretinal surgery. Retina-Vitreus, Cilt: 14 - Sayı: 4, 321–328. https://ajindex.com/articles/305269

References (17)

  1. Cibis PA, Becker B, Okun E, et al.: The use of liquid silicone in retinal detachment surgery. Arch Ophthalmol. 1962;68:590-599
  2. Armaly MF: Ocular tolerance to silicones. Arch Ophthalmol. 1962;68:390
  3. Haut J, Ullern M, VanEffenterre G, et al.: Utilisation du silicone intra-oculaire a â propos de 200 cas. Soc Ophtalmol Fr. 1979,79:797
  4. Scott JD: Use of liquid silicone in vitrectomised eyes. Dev Ophthalmol. 1981;2:1 85
  5. Ference, M, Lemon, HB, and Stephenson, RJ: Analytical experimental physics, ed 2, Chicago, 1956, University of Chicago Press, pp. 141-168
  6. Champion, R, Faulborn, J, Bowald, et al.: Peritoneal reaction to liquid silicone: an experimental study, Graefes Arch Clin Exp Ophthalmol. 1987;225:141-145
  7. Heidenkummer H, Kampik A, Thierfelder S: Experimental evaluation of in vitro stability of purified polydimethylsiloxanes (silicone oil) in viscosity ranges from 1000 to 5000 centistokes. Retina. 1992;12:28
  8. Peyman GA, Ericson ES, May DR: A review of substances and techniques of vitreous replacement. Surv Ophthalmol. 1972; 17:41
  9. Haut J, Ullern M, Chermet M, et al.: Complications of intraocular injections of silicone combined with vitrectomy. Ophthalmologi-ca. 1980;180:29
  10. Leaver PK: Vitrectomy and fluid/silicon oil exchange for giant retinal tears: 10-year follow up. German J Ophthalmol. 1993;2: 20-23
  11. The Retina Society Terminology Committee: The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 1983; 90:121. 1 2- Machemer R: Proliferative vitreoretinopathy (PVR): A personal account of its pathogenesis and treatment. Proctor Lecture. Invest Ophthalmol Vis Sci. 1988;29:1771 -1783
  12. Cowley M, Conway Bl^ Campochiaro PA, et al.: Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol. 1989;107:1147-1151
  13. Bonnet M: The development of severe proliferative vitreoretinopathy after retinal detachment surgery. Grade B: A determining risk factor. Graefes Arch Clin Exp Ophthalmol. 1988;226:201 -205
  14. Ho PC, Yoshida A, Schepens CL, et al: Severe proliferative vitreoretinopathy and retinal detachment
  15. Initial clinical findings. Ophthalmology. 1984;91:1531 -1537
  16. Silicone Study Group: Vitrectomy with silicone oil or sulfur hexaf-luoride gas in eyes with severe proliferative vitreoretinopathy: Results of a randomized clinical trial: Report 1. Arch Ophthalmol. 1992;l 10:770
  17. Silicone Study Group: Vitrectomy with silicone oil or perfluorop-ropane gas in ey